ReviewGeriatrics & gerontology international2026
Postprandial Hypotension-Methods for the Evaluation and Management.
Review in Geriatrics & gerontology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Postprandial hypotension (PPH) is a common but underrecognized condition in older adults that affects nearly half of the population and is frequently associated with autonomic dysfunction. Unlike orthostatic hypotension (OH), PPH often presents with sleepiness and syncope. Its prevalence and severity are influenced by meal composition, particularly carbohydrate content, and the time of day, with morning meals posing a greater risk. Its pathophysiology involves splanchnic blood pooling, altered gastric emptying, impaired baroreflex function, and intestinal peptide activity, including those of glucagon-like peptide (GLP)-1 and GLP-2. Despite its clinical significance, PPH lacks standardized diagnostic criteria. Conventional blood pressure (BP) measurements, ambulatory BP monitoring (ABPM), and home BP monitoring (HBPM) have been used to detect PPH, with ABPM offering continuous data and HBPM providing practical position-controlled assessments. However, variability in test meals and measurement protocols limits consistency across studies. Management primarily involves lifestyle modifications, such as premeal water intake, smaller and low-carbohydrate meals, and postprandial exercise. Pharmacological interventions, including acarbose, which targets PPH associated with autonomic dysfunction, may be considered in select cases. Emerging therapies involving gut peptides, such as GLP-1 analogs and DPP-4 inhibitors, show promise, especially in patients with α-synucleinopathies. PPH frequently coexists with OH and supine hypertension, complicating diagnosis and treatment. Screening for positional BP dysregulation and tailoring interventions for individual autonomic profiles are essential. Given its association with cardiovascular events and mortality, the improved recognition and management of PPH are critical in geriatric care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.